Daewon Pharmaceutical Co., Ltd.

Daewon Pharmaceutical Co., Ltd.

003220.KS
Daewon Pharmaceutical Co., Ltd.KR flagKorea Exchange
7,790.00
KRW
-210.00
- -
166.97BMarket Cap

Daewon Pharmaceutical Co., Ltd. (003220.KS) Stock Split History

Learn about Daewon Pharmaceutical Co., Ltd.'s most recent 103-for-100 basis stock split on March 07, 2022. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Daewon Pharmaceutical Co., Ltd.'s most recent stock split

Split Date: 2022-03-07
Split Ratio: 103:100
Price Before Split: $19776.00
Price After Split: $19200.00

Developer API

Get 003220.KS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/003220.KS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.03 times more shares (a 103:100 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Daewon Pharmaceutical Co., Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2022-03-07103:100No$19776.00$19200.00
2021-02-1821:20No$18637.49$17749.99
2020-02-17103:100No$15759.07$15300.07
2019-02-11103:100No$17510.06$17000.06
2018-02-1921:20No$21420.07$20400.06
2017-02-07103:100No$21269.54$20650.04
2016-02-18103:100No$18643.01$18100.01
2015-03-0221:20No$18847.50$17950.00
2014-01-2821:20No$13334.99$12699.99
2013-01-3111:10No$11274.98$10249.98
2011-12-2811:10No$5329.49$4844.99
2007-12-242:1No$11450.01$5725.00
2004-04-305:2No$13249.94$5299.98
2003-12-2921:20No$13859.98$13199.99

About Daewon Pharmaceutical Co., Ltd.

Company overview and industry information

Daewon Pharmaceutical Co., Ltd. (003220.KS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 103-for-100 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Daewon Pharmaceutical Co., Ltd. Summary

Last updated: 7/13/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.